Prosecution Insights
Prosecution Insights
103 pending office actions • 59 art units • 98 examiners • 0 of 103 (0%) have an AI response strategy ready • 139 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 32 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 32 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 2 (2%) |
| §101 + other | 8 (8%) |
| §103 only | 34 (33%) |
| §102 only | 2 (2%) |
| §112 only | 7 (7%) |
| Double-patenting only | 5 (5%) |
| Double-patenting + other | 9 (9%) |
| Multi-statute (no §101) | 35 (34%) |
| No statute on record | 1 (1%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PENNINGTON, KATIE LEIGH | 3 | 27.6% | +58.4% |
| KONOPKA, CATHERINE ANNE | 2 | 58.2% | +64.5% |
| NGUYEN, QUANG | 2 | 38.1% | +53.0% |
| CHATTERJEE, JAYANTA | 2 | 47.4% | +76.9% |
| SILVA, MICHAEL THOMAS | 1 | 32.7% | +21.3% |
| KENNEDY, TIMOTHY J | 1 | 71.1% | +17.5% |
| MCFARLAND-BARNES, KELAH JANAE | 1 | 100.0% | +0.0% |
| HANEY, AMANDA MARIE | 1 | 36.5% | +44.5% |
| BLAISE, BRADFORD CHRISTOPHER | 1 | 60.6% | +32.0% |
| YOUNGBLOOD, WILLIAM JUSTIN | 1 | 61.9% | +40.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19025063 | SYSTEM AND METHOD FOR PERFORMING MULTICAST AUTHENTICATION IN NETWORK-ON-CHIP SYSTEMS | MCFARLAND-BARNES, KELAH JANAE | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18552486 | PREDICTION OF POST-OPERATIVE PAIN USING HOSVD | STONE, RACHAEL SOJIN | 77d overdue |
| 17772266 | GENE THERAPY VECTORS | PENNINGTON, KATIE LEIGH | 51d overdue |
| 18316064 | DISTRIBUTED LEDGER PLATFORM FOR ELECTRONIC VOTING AND/OR POLLING | LEE, CLAY C | 35d overdue |
| 18264605 | ABERRATION CORRECTED OPTICAL ASSEMBLY | LEI, JIE | 28d overdue |
| 17802872 | COMPOUNDS THAT MODULATE ANTI-TUMOR IMMUNITY AND METHODS OF DOING THE SAME | HEITMEIER, KENDALL NICOLE | 24d overdue |
| 18032648 | METHOD FOR TREATING ALS/FTD THROUGH DEGRADATION OF RNA REPEAT EXPANSION | TOWNSLEY, SARA ELIZABETH | 15d overdue |
| 18191790 | AAV-BASED GENE THERAPY FOR MULTIPLE SCLEROSIS | NGUYEN, QUANG | 9d overdue |
| 18007308 | THERAPEUTIC USES OF GLUCOCORTICOIDS WITH ANABOLIC EFFECTS IN SKELETAL MUSCLE | CORNET, JEAN P | 9d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19012392 | METHODS OF IMPROVING SURVIVAL AND ELIMINATING TREATMENT-LIMITING TOXICITIES OF DICHLOROACETATE IN PATIENTS WITH PYRUVATE DEHYDROGENASE COMPLEX DEFICIENCY | HANEY, AMANDA MARIE | 163d overdue |
| 17772266 | GENE THERAPY VECTORS | PENNINGTON, KATIE LEIGH | 51d overdue |
| 18191790 | AAV-BASED GENE THERAPY FOR MULTIPLE SCLEROSIS | NGUYEN, QUANG | 9d overdue |
| 18114014 | T-DNA Free Gene Editing through Transient Suppressing POLQ in Plants | CHATTERJEE, JAYANTA | 5d overdue |
| 18267144 | METHOD FOR PROGRAMMABLE CONTROL OF RNA TRANSCRIPT LEVELS WITH AUTOREGULATED CRISPR-CAS13D | KONOPKA, CATHERINE ANNE | 20d |
| 18701456 | Insect Toxin Delivery Mediated by a Begomovirus Coat Protein | CHATTERJEE, JAYANTA | 33d |
| 19324860 | VEHICLE SECURITY ANALYSIS PLATFORM | SILVA, MICHAEL THOMAS | — |
| 19199855 | MAGNETIC STEREOLITHOGRAPHY PRINT HEAD, STEREOLITHOGRAPHY PRINTER, AND METHOD OF STEREOLITHOGRAPHY PRINTING | KENNEDY, TIMOTHY J | — |
| Art Unit | Apps |
|---|---|
| 1631 | 6 |
| 1662 | 4 |
| 1635 | 4 |
| 1634 | 4 |
| 1636 | 4 |
| 1645 | 3 |
| 1628 | 3 |
| 1671 | 3 |
| 1637 | 3 |
| 2431 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19324860 | VEHICLE SECURITY ANALYSIS PLATFORM | SILVA, MICHAEL THOMAS | 3663 | §103§112 | Non-Final OA | — | Pending | Sep 10, 2025 |
| 19199855 | MAGNETIC STEREOLITHOGRAPHY PRINT HEAD, STEREOLITHOGRAPHY PRINTER, AND METHOD OF STEREOLITHOGRAPHY PRINTING | KENNEDY, TIMOTHY J | — | §102§103§112 | Non-Final OA | — | Pending | May 06, 2025 |
| 19025063 | SYSTEM AND METHOD FOR PERFORMING MULTICAST AUTHENTICATION IN NETWORK-ON-CHIP SYSTEMS | MCFARLAND-BARNES, KELAH JANAE | 2431 | §103 | Non-Final OA | — | Pending | Jan 16, 2025 |
| 19012392 | METHODS OF IMPROVING SURVIVAL AND ELIMINATING TREATMENT-LIMITING TOXICITIES OF DICHLOROACETATE IN PATIENTS WITH PYRUVATE DEHYDROGENASE COMPLEX DEFICIENCY | HANEY, AMANDA MARIE | 1682 | §103DP | Non-Final OA | 163d overdue | Pending | Jan 07, 2025 |
| 18835643 | METHOD, APPARATUS, AND SYSTEM FOR MANUAL SURGICAL DISSECTION | BLAISE, BRADFORD CHRISTOPHER | 3794 | — | Non-Final OA | — | Pending | Aug 02, 2024 |
| 18728925 | PROCESS FOR SYNTHESIS OF GALBULIMIMA ALKALOID 18 AND COMPOUNDS USEFUL AS OPIOID RECEPTOR ANTAGONISTS AND AGONISTS | YOUNGBLOOD, WILLIAM JUSTIN | — | §112 | Non-Final OA | — | Pending | Jul 15, 2024 |
| 18717509 | BCL-XL/BCL-2 DUAL DEGRADERS FOR TREATMENT OF CANCERS | AULAKH, CHARANJIT | — | §112 | Non-Final OA | — | Pending | Jun 07, 2024 |
| 18716013 | METHOD, APPARATUS, AND SYSTEM FOR REMOVAL OF LESIONS | TEMPLETON, MARINA DELANEY | 3794 | §102§103 | Non-Final OA | — | Pending | Jun 03, 2024 |
| 18664736 | RUNTIME SECURITY MONITORING OF HARDWARE | DOAN, TRANG T | 2431 | §103 | Final Rejection | — | Pending | May 15, 2024 |
| 18706881 | IMPROVED GENETIC TRANSFORMATION BY IMPROVING DE-NOVO SHOOT REGENERATION IN ADULT PLANTS AND DURING IN-VITRO TISSUE CULTURE | JOHNSON, EMILY KATHARINE | 1662 | §102§103§112 | Final Rejection | — | Pending | May 02, 2024 |
| 18700643 | METHODS OF TREATING DISEASES ASSOCIATED WITH SENESCENT CELL ACCUMULATION | CHANDRAKUMAR, NIZAL S | 1625 | §103§112 | Non-Final OA | — | Pending | Apr 11, 2024 |
| 18623087 | CYANOBACTERIAL HOSTS AND METHODS FOR PRODUCING CHEMICALS | MORGAN, BAILEY MICHELLE | 1645 | §103DP | Non-Final OA | — | Pending | Apr 01, 2024 |
| 18598468 | IL-1RA CDNAS | ROBINSON, HOPE A | 1652 | §103§112 | Non-Final OA | 75d | Pending | Mar 07, 2024 |
| 18293040 | ENGINEERING AAV VECTORS WITH IMPROVED CNS TARGETING | BARRON, SEAN C | 1653 | §103 | Non-Final OA | — | Pending | Jan 29, 2024 |
| 18580710 | EARLY DETECTION OF INNATE IMMUNE DYSFUNCTION AND TREATMENT OF CONDITIONS ASSOCIATED THEREWITH | MACFARLANE, STACEY NEE | 1645 | §101§102§103§112Other | Non-Final OA | — | Pending | Jan 19, 2024 |
| 18536973 | AUTOMATED TEST PATTERN GENERATION FOR TESTING DESIGN REDACTING RECONFIGURABLE HARDWARE | BARNETT, JACK KENSINGTON | 2111 | §103§112 | Final Rejection | — | Pending | Dec 12, 2023 |
| 18567763 | GENE THERAPY FOR DUCHENNE MUSCULAR DYSTROPHY | VYAS, KEYUR ANILKUMAR | — | §102§103§112 | Non-Final OA | — | Pending | Dec 06, 2023 |
| 18287690 | MULTIFACETED APPROACH TO NOVEL INTERLEUKIN-6 INHIBITORS | BARSKY, JARED | 1628 | DP | Non-Final OA | — | Pending | Oct 20, 2023 |
| 18287711 | AAVRH74 VECTORS FOR GENE THERAPY OF MUSCULAR DYSTROPHIES | SULLIVAN, STEPHANIE LAUREN | 1635 | §103§112DP | Non-Final OA | — | Pending | Oct 20, 2023 |
| 18287368 | AGENTS FOR MANUFACTURE OF CO-ASSEMBLING PEPTIDES | JAUHARI, SACHI | 1654 | §103§112 | Non-Final OA | — | Pending | Oct 18, 2023 |
| 18484830 | WIRELESS CHARGING AND NEAR-FIELD COMMUNICATION (NFC) INTEGRATION | FANTU, YALKEW | — | §103 | Non-Final OA | — | Pending | Oct 11, 2023 |
| 18286025 | METHODS, KITS, AND APPROACHES FOR VIRAL VACCINES | GILL, RACHEL B | 1671 | §101§102§112Other | Non-Final OA | 8d | Pending | Oct 06, 2023 |
| 18552486 | PREDICTION OF POST-OPERATIVE PAIN USING HOSVD | STONE, RACHAEL SOJIN | 3681 | §101§103 | Non-Final OA | 77d overdue | Pending | Sep 26, 2023 |
| 18282503 | CHIMERIC PHAGOCYTIC RECEPTORS FOR TREATMENT OF NEURODEGENERATIVE DISORDERS | HUYNH, PHUONG N | 1641 | §103§112 | Non-Final OA | — | Pending | Sep 15, 2023 |
| 18241443 | METALLOPOLYMERS AND ICLICK SYNTHESIS THEREOF | MCCULLEY, MEGAN CASSANDRA | 1767 | §112 | Non-Final OA | — | Pending | Sep 01, 2023 |
| 18277969 | METHODS AND COMPOSITIONS TO CONFER REGULATION TO GENE THERAPY CARGOES BY HETEROLOGOUS USE OF ALTERNATIVE SPLICING CASSETTES | ZARA, JANE J | 1637 | §103§112DP | Non-Final OA | — | Pending | Aug 18, 2023 |
| 18264605 | ABERRATION CORRECTED OPTICAL ASSEMBLY | LEI, JIE | 2872 | §102§103 | Non-Final OA | 28d overdue | Pending | Aug 08, 2023 |
| 18274980 | TREATING DISORDERS ASSOCIATED WITH DYRK1A DYSFUNCTION | KATAKAM, SUDHAKAR | 1658 | §103 | Non-Final OA | — | Pending | Jul 28, 2023 |
| 18263008 | ENHANCING METABOLIC FITNESS OF T CELLS TO TREAT CANCER | DUNN, LINDSAY MICHELLE | 1644 | §102§103 | Non-Final OA | 83d | Pending | Jul 26, 2023 |
| 18268280 | CREATE HUANGLONGBING TOLERANCE BY SILENCING A CITRUS NEGATIVE IMMUNE REGULATOR | DELEO, VICTORIA LYNN | 1662 | §102§103 | Final Rejection | — | Pending | Jun 19, 2023 |
| 18267144 | METHOD FOR PROGRAMMABLE CONTROL OF RNA TRANSCRIPT LEVELS WITH AUTOREGULATED CRISPR-CAS13D | KONOPKA, CATHERINE ANNE | 1635 | §103§112 | Final Rejection | 20d | Pending | Jun 14, 2023 |
| 18257237 | DIPHENHYDRAMINE AND LACTOFERRIN FOR PREVENTION AND TREATMENT OF COVID-19 | COFFA, SERGIO | 1658 | DP | Final Rejection | 56d | Pending | Jun 13, 2023 |
| 18327296 | FUNCTIONAL VERIFICATION FLOW OF OBFUSCATED DESIGNS FOR CIRCUITS | NGUYEN, NHA T | 2851 | §103 | Final Rejection | — | Pending | Jun 01, 2023 |
| 18038321 | USE OF INSULIN-LIKE GROWTH FACTORS WITH GAMMA-CHAIN CYTOKINES TO INDUCE HOMEOSTATIC PROLIFERATION OF LYMPHOCYTES | SULLIVAN, DENNIS JOHN | 1642 | §103 | Non-Final OA | — | Pending | May 23, 2023 |
| 18316064 | DISTRIBUTED LEDGER PLATFORM FOR ELECTRONIC VOTING AND/OR POLLING | LEE, CLAY C | 3699 | §101§103 | Final Rejection | 35d overdue | Pending | May 11, 2023 |
| 18314773 | USE OF AAV-EXPRESSED M013 PROTEIN AS AN ANTI-INFLAMMATORY THERAPEUTIC | NGUYEN, QUANG | 1631 | §103§112 | Non-Final OA | — | Pending | May 09, 2023 |
| 18032648 | METHOD FOR TREATING ALS/FTD THROUGH DEGRADATION OF RNA REPEAT EXPANSION | TOWNSLEY, SARA ELIZABETH | 1629 | §102§112Other | Non-Final OA | 15d overdue | Pending | Apr 19, 2023 |
| 18191790 | AAV-BASED GENE THERAPY FOR MULTIPLE SCLEROSIS | NGUYEN, QUANG | 1631 | §103§112 | Final Rejection | 9d overdue | Pending | Mar 28, 2023 |
| 18026389 | COMPOSITIONS AND METHODS FOR MODULATION OF BACTERIAL GENE EXPRESSION | RYAN, DOUGLAS CHARLES | 1635 | §112 | Non-Final OA | — | Pending | Mar 15, 2023 |
| 18114014 | T-DNA Free Gene Editing through Transient Suppressing POLQ in Plants | CHATTERJEE, JAYANTA | 1662 | §103 | Final Rejection | 5d overdue | Pending | Feb 24, 2023 |
| 18042424 | SILK PARTICLES ENCAPSULATING OXYGEN CARRIERS AS ARTIFICIAL BLOOD SUBSTITUTE | JANOSKO, CHASITY PAIGE | 1613 | §103 | Non-Final OA | — | Pending | Feb 21, 2023 |
| 18007308 | THERAPEUTIC USES OF GLUCOCORTICOIDS WITH ANABOLIC EFFECTS IN SKELETAL MUSCLE | CORNET, JEAN P | 1628 | §103§112 | Final Rejection | 9d overdue | Pending | Jan 30, 2023 |
| 18017726 | IMPROVED AAV-MEDIATED X-LINKED RETINOSCHISIS THERAPIES | STUART, CAREY ALEXANDER MC | 1671 | §103 | Final Rejection | — | Pending | Jan 24, 2023 |
| 17925054 | COMPOSITIONS AND METHODS OF DETECTION OF PRE-SYMPTOMATIC ALS | MYERS, CARLA J | 1682 | §101 | Final Rejection | — | Pending | Nov 14, 2022 |
| 17924539 | DISEASE CORRECTION BY DELIVERY OF AAV8 VECTORS EXPRESSING CODON OPTIMIZED NAGLU | PENNINGTON, KATIE LEIGH | 1634 | §103§112 | Final Rejection | — | Pending | Nov 10, 2022 |
| 17922174 | MACHINE GUIDED DIRECTED EVOLUTION OF RAAV COMBINATORIAL CAPSID LIBRARIES | PENNINGTON, KATIE LEIGH | 1634 | §103 | Non-Final OA | — | Pending | Oct 28, 2022 |
| 17919052 | ENHANCED EFFECTS OF GENE-IMMUNOTHERAPY AND IMMUNOSUPPRESSANTS IN MULTIPLE SCLEROSIS | SHIBUYA, MARK LANCE | 1631 | §103Other | Non-Final OA | 3d overdue | Pending | Oct 14, 2022 |
| 17918887 | ENHANCING AAV-MEDIATED DELIVERY AND TRANSDUCTION WITH POLYVINYL ALCOHOL | POPA, ILEANA | 1633 | §103 | Non-Final OA | 30d overdue | Pending | Oct 13, 2022 |
| 18045873 | AAV VARIANTS WITH HOST ANTIBODY ESCAPE CAPABILITIES AND ALTERED TISSUE TARGETING PROPERTIES | KONOPKA, CATHERINE ANNE | 1635 | §103DP | Final Rejection | — | Pending | Oct 12, 2022 |
| 17918052 | SHEATH/CATHETER SECURING DEVICE | ALLEN, ROBERT F | 3783 | §102§103 | Non-Final OA | 27d | Pending | Oct 10, 2022 |
| 17911026 | METHODS, DEVICES, AND COMPOSITIONS FOR LESION REPAIR AND PREVENTION | NGUYEN, NGOC-ANH THI | 1615 | §103 | Final Rejection | — | Pending | Sep 12, 2022 |
| 17906098 | MODIFIED ARRESTIN-1 TO ENHANCE PHOTORECEPTOR SURVIVAL IN RETINAL DISEASE | KIM, TAEYOON | 1631 | §103 | Non-Final OA | 5d overdue | Pending | Sep 12, 2022 |
| 17910327 | AFFINITY MATURED AND HUMANIZED BINDING DOMAINS TARGETING ROR2 | BRISTOL, LYNN ANNE | 1643 | §112 | Non-Final OA | — | Pending | Sep 08, 2022 |
| 17802872 | COMPOUNDS THAT MODULATE ANTI-TUMOR IMMUNITY AND METHODS OF DOING THE SAME | HEITMEIER, KENDALL NICOLE | 1621 | §102§103§112 | Final Rejection | 24d overdue | Pending | Aug 26, 2022 |
| 17800687 | Multilamellar RNA Nanoparticles and Methods of Sensitizing Tumors to Treatment with Immune Checkpoint Inhibitors | ZOU, NIANXIANG | 1671 | §103§112DP | Non-Final OA | 19d overdue | Pending | Aug 18, 2022 |
| 17797770 | CYCLIC POLYACETYLENE AND METHODS OF PREPARING THE SAME | FEELY, MICHAEL J | 1763 | §103 | Non-Final OA | — | Pending | Aug 05, 2022 |
| 17797810 | RNA-LOADED NANOPARTICLES AND USE THEREOF FOR THE TREATMENT OF CANCER | ANGELL, JON E | 1637 | §103§112 | Final Rejection | — | Pending | Aug 05, 2022 |
| 17863172 | LEARNING-ROOTED IOT PLATFORM | CHEN, CAI Y | 2425 | §102§103 | Final Rejection | — | Pending | Jul 12, 2022 |
| 17788519 | IMMUNOTHERAPY FOR DIRECT REPROGRAMMING OF CANCER CELLS INTO IMMUNE CELLS/ANTIGEN PRESENTING CELLS/DENDRITIC CELLS | DACE DENITO, ALEXANDRA GERALDINE | 1636 | §103§112Other | Non-Final OA | 9d | Pending | Jun 23, 2022 |
| 17772266 | GENE THERAPY VECTORS | PENNINGTON, KATIE LEIGH | 1634 | §102§103§112 | Non-Final OA | 51d overdue | Pending | Apr 27, 2022 |
| 17762543 | VACCINE THERAPY FOR RAN PROTEIN DISEASES | WANG, CHANG YU | 1675 | DP | Non-Final OA | 35d | Pending | Mar 22, 2022 |
| 17635631 | ARYL AND PYRIDYL AMIDE PESTICIDES AND COMPOSITIONS THEREOF | CHENG, KAREN | 1623 | §102§103§112 | Non-Final OA | 26d | Pending | Feb 15, 2022 |
| 17621029 | STRUCTURALLY DEFINED SIRNA-DUAL VARIABLE DOMAIN IMMUNOGLOBULIN CONJUGATES | TRAN, CHRISTINA L | 1637 | §112 | Non-Final OA | — | Pending | Dec 20, 2021 |
| 17603302 | MODIFIED AAV VECTORS THAT DAMPEN THE HUMORAL IMMUNE RESPONSE | WANG, RUIXUE | 1672 | §103 | Final Rejection | 31d overdue | Pending | Oct 12, 2021 |
| 17428749 | METHODS FOR TARGETED TREATMENT AND PREDICTION OF PATIENT SURVIVAL IN CANCER | HAMMELL, NEIL P | 1681 | §101§103§112 | Non-Final OA | — | Pending | Aug 05, 2021 |
| 17228298 | ENGINEERED RECEPTOR/LIGAND SYSTEM FOR DELIVERY OF THERAPEUTIC AGENTS | ZAHORIK, AMANDA MARY | 1636 | §103§112 | Final Rejection | — | Pending | Apr 12, 2021 |
| 17272203 | ADENO-ASSOCIATED VIRAL VECTORS FOR THE TREATMENT OF BEST DISEASE | BATES, KEENAN ALEXANDER | 1631 | §103 | Non-Final OA | — | Pending | Feb 26, 2021 |
| 16972740 | AAV CARDIAC GENE THERAPY FOR CARDIOMYOPATHY | SU-TOBON, QIWEN NMN | 1636 | DP | Non-Final OA | — | Pending | Dec 07, 2020 |
| 16340738 | METHOD AND APPARATUS FOR IMPROVED DETERMINATION OF NODE INFLUENCE IN A NETWORK | LIU, GUOZHEN | 1686 | §101§103§112 | Final Rejection | 9d overdue | Pending | Apr 10, 2019 |
| 19094455 | SYSTEMS AND METHODS FOR AUTOMATED BUILDING CODE CONFORMANCE | SITTNER, MATTHEW T | 3629 | §101§103 | Non-Final OA | 5d overdue | Pending | Mar 28, 2025 |
| 19100617 | COMPOSITIONS, KITS, METHODS, AND METHODS OF ADMINISTRATION RELATING TO EDWARDSIELLA PISCICIDA VACCINE AND/OR ANTIGEN DELIVERY VECTOR SYSTEMS | HAUK TEODORO, PRICILA NMN | 1645 | §103 | Non-Final OA | — | Pending | Feb 03, 2025 |
| 19020470 | AI-ASSISTED CODE COMPLIANCE CHECKING FOR BUILDING AND LAND DEVELOPMENT | BEARD, CHARLES LLOYD | — | §103Other | Non-Final OA | — | Pending | Jan 14, 2025 |
| 18751835 | TEXTURIZED INSECTICIDAL FORMULATION | PHAN, DOAN THI-THUC | 1613 | §103DP | Non-Final OA | — | Pending | Jun 24, 2024 |
| 18747334 | METAMATERIAL-BASED COMPACT ANTENNA-IN-PACKAGE SOLUTIONS IN FREQUENCY HANDOVER APPLICATIONS | BACK, AUSTIN M | 2845 | §103 | Final Rejection | — | Pending | Jun 18, 2024 |
| 18720869 | SYSTEMS AND METHODS FOR FUNCTIONAL TASK PREDICTION USING DYNAMIC SUPERVOXEL PARCELLATIONS | MCDONALD, JAMES F | 3797 | §103§112 | Non-Final OA | — | Pending | Jun 17, 2024 |
| 18669673 | COUNTER-FLOW POINT EMBEDDED ELECTRODE FOR DYNAMIC STALL CONTROL | GLOVER, SHANNA DANIELLE | 3642 | §103 | Non-Final OA | — | Pending | May 21, 2024 |
| 18701456 | Insect Toxin Delivery Mediated by a Begomovirus Coat Protein | CHATTERJEE, JAYANTA | 1662 | §103Other | Final Rejection | 33d | Pending | Apr 15, 2024 |
| 18691666 | CELLULAR THERAPY TO SUPPRESS IMMUNE RESPONSE | METCALF, MATTHEW CURRAN | — | §103 | Non-Final OA | — | Pending | Mar 13, 2024 |
| 18689470 | NOVEL COMPOUNDS FOR MANAGEMENT OF BACTERIAL SPOT DISEASE IN TOMATO | HEASLEY, MEGHAN CHRISTINE | 1626 | §102§103§112 | Final Rejection | — | Pending | Mar 06, 2024 |
| 18682048 | VIRTUAL BUILDING CONSTRUCTION INSPECTION FOR PERMITTING | EDMONDS, DONALD J | 3629 | §101 | Non-Final OA | — | Pending | Feb 07, 2024 |
| 18580480 | HYBRID ELECTROMECHANICAL TRANSFORMER | KLIMOWICZ, WILLIAM JOSEPH | — | §103 | Non-Final OA | — | Pending | Jan 18, 2024 |
| 18408124 | FORM GENERATION FOR BUILDING CONSTRUCTION ADDIN | MOLNAR, HUNTER A | 3628 | §101§103 | Non-Final OA | — | Pending | Jan 09, 2024 |
| 18567951 | MAGNESIUM-LITHIUM ALLOYS COMPOSED OF GALLIUM OR INDIUM | WALCK, BRIAN D | 1738 | §102 | Non-Final OA | — | Pending | Dec 07, 2023 |
| 18566914 | MAGNETIC NON-DESTRUCTIVE ANALYSIS AND TESTING FOR ULTRA-HIGH PERFORMANCE CONCRETE | MONSUR, NASIMA | 2858 | §103 | Non-Final OA | — | Pending | Dec 04, 2023 |
| 18243866 | SILICON PROMOTED SINGLE WALL CARBON NANOTUBE SYNTHESIS | PIRO, NICHOLAS ANTHONY | 1738 | §103§112 | Non-Final OA | — | Pending | Sep 08, 2023 |
| 18267184 | HIGH DIMENSIONAL AND ULTRAHIGH DIMENSIONAL DATA ANALYSIS WITH KERNEL NEURAL NETWORKS | COVINGTON, AMANDA R | 3686 | §103 | Final Rejection | — | Pending | Jun 14, 2023 |
| 18204602 | SELF-ASSEMBLED THIN CARBON NANOTUBE FILMS USING AMPHIPHILIC PENDANT POLYMER DISPERSANTS | NGUYEN, HAIDUNG D | 1761 | §102§103 | Non-Final OA | — | Pending | Jun 01, 2023 |
| 18245947 | DEVICES, SYSTEMS, AND METHODS RELATED TO NUCLEIC ACID ISOLATION | SINES, BRIAN J | 1796 | §103 | Final Rejection | 12d | Pending | Mar 20, 2023 |
| 18013954 | EXERGY-BASED LIFE CYCLE ASSESSMENT OF BUILDINGS | YESILDAG, MEHMET | 3624 | §102 | Final Rejection | 5d overdue | Pending | Dec 30, 2022 |
| 18013359 | IN-SITU SERVO-HYDRAULIC BIO-MANIPULATOR | HUANG, MICKEY NMN | 1758 | §103 | Final Rejection | — | Pending | Dec 28, 2022 |
| 18013200 | PERFUSION-ENABLED BIOREACTOR | KRCHA, MATTHEW D | 1796 | §102§103§112 | Non-Final OA | — | Pending | Dec 27, 2022 |
| 17925776 | BENZOYLHYDRAZIDE-DERIVED HDAC DEGRADERS AS THERAPEUTICS FOR TREATING CANCER AND OTHER HUMAN DISEASES | SCHMIDT, IZABELA MARIA | 1621 | DP | Final Rejection | — | Pending | Nov 16, 2022 |
| 17912690 | GENE THERAPY FOR COCKAYNE SYNDROME | SINGH, ANOOP KUMAR | 1632 | §102§103§112 | Final Rejection | — | Pending | Sep 19, 2022 |
| 17906508 | DEUTERIUM MAGNETIC RESONANCE IMAGING | WESTERBERG, NISSA M | 1618 | §103§112 | Non-Final OA | — | Pending | Sep 16, 2022 |
| 17802686 | COMPOSITIONS, METHODS, KITS, AND SYSTEMS RELATING TO CHARGE-NEUTRAL MICROGELS FOR 3D CELL CULTURE AND PRINTING | KASAYAN, KATRIEL BARCELLANO | 1634 | §103 | Final Rejection | — | Pending | Aug 26, 2022 |
| 17626674 | MULTILAMELLAR RNA NANOPARTICLES | VANHORN, ABIGAIL LOUISE | 1636 | §103Other | Final Rejection | 30d | Pending | Jan 12, 2022 |
| 17565972 | CELLULAR MICRO-MASONRY SYSTEM | NGUYEN, HENRY H | 1758 | §103 | Non-Final OA | 18d overdue | Pending | Dec 30, 2021 |
| 17622102 | SYSTEMS AND METHODS RELATING TO THREE-DIMENSIONAL (3D) CELL MANUFACTURING | BEHARRY, ZANNA MARIA | 1632 | §103 | Non-Final OA | — | Pending | Dec 22, 2021 |
| 17281714 | ALDEHYDE CROSSLINKING, PROTEIN BASED TISSUE SCAFFOLDS, AND USES THEREOF | LEE, CHIHYI NMN | 1628 | §103§112 | Non-Final OA | — | Pending | Mar 31, 2021 |
| 17025664 | HANDHELD SENSOR FOR RAPID, SENSITIVE DETECTION AND QUANTIFICATION OF SARS-CoV-2 FROM SALIVA | LUSI, ELLIS FOLLETT | 1677 | §112 | Non-Final OA | 9d overdue | Pending | Sep 18, 2020 |
| 17928400 | CRISPR/CAS CHAIN REACTION SYSTEMS AND METHODS FOR AMPLIFYING THE DETECTION SENSITIVITY OF CRISPR-BASED TARGET DETECTION | BAUSCH, SARAE L | 1699 | §102§103§112DP | Final Rejection | — | Pending | Nov 29, 2022 |
| 17286151 | MAGNETICALLY RESPONSIVE COMPOSITE MICROPARTICLES FOR TRIGGERED DELIVERY OF BIOLOGICALLY ACTIVE AGENTS | HOERNER, PAUL ELLSWORTH | 1611 | §103 | Non-Final OA | — | Pending | Apr 16, 2021 |
| 16968941 | DECELLULARIZED TISSUES, HYDROGELS THEREOF, AND USES THEREOF | ZHU, JIANJIAN | 1631 | §112DP | Final Rejection | — | Pending | Aug 11, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial